Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial

View ORCID ProfileSuresh B. Patankar, Hrishikesh Rangnekar, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Anupama Gorde, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje
doi: https://doi.org/10.1101/2021.05.14.21256900
Suresh B. Patankar
1AMAI Charitable Trust, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Suresh B. Patankar
  • For correspondence: sureshpatankarace{at}gmail.com
Hrishikesh Rangnekar
2Quest Clinical Services, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kalpana Joshi
3Dept. of Biotechnology, Sinhgad College of Engineering, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kishor Suryawanshi
4YCM Hospital, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pravin Soni
4YCM Hospital, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anupama Gorde
5Sinhgad Institute of Dental Sciences, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tejas Shah
6Krsnaa Diagnostics Pvt. Ltd. Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sagar Patankar
1AMAI Charitable Trust, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diwakar Jha
8SHRIPAD Medisearch Pvt. Ltd., Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajesh Raje
1AMAI Charitable Trust, Pune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading
  • Protocol--EC Approved[supplements/256900_file02.pdf]
  • Consort Checklist[supplements/256900_file03.pdf]
  • ETHICS STATEMENT[supplements/256900_file04.pdf]
Back to top
PreviousNext
Posted May 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial
Suresh B. Patankar, Hrishikesh Rangnekar, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Anupama Gorde, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje
medRxiv 2021.05.14.21256900; doi: https://doi.org/10.1101/2021.05.14.21256900
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial
Suresh B. Patankar, Hrishikesh Rangnekar, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Anupama Gorde, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje
medRxiv 2021.05.14.21256900; doi: https://doi.org/10.1101/2021.05.14.21256900

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)